Swine Flu Vaccine Being Tested by GlaxoSmithKline
GlaxoSmithKline has announced the beginning of testing of its swine flu vaccine on humans.
Press Release Service – Wired PR News – GlaxoSmithKline has reportedly begun to test its swine flu vaccination on human beings. As reported by the Associated Press (AP), the drugmaker made the announcement Friday, citing plans to conduct 16 clinical trials for the vaccine on thousands of individuals in North America and Europe.
Alexandra Harrison, a spokesperson for the company is quoted by the AP as stating of expectations that the vaccine will be on the market soon, despite the trials being scheduled to last for approximately one year, “We aim to get the first doses out in September.” Harrison is further noted to state that the initial trial is being done in Germany.
As noted by the AP, other pharmaceutical companies have begun testing of their own swine flu vaccinations as well.
WiredPRNews.com – The latest in Health News
Photo Credit: Wikipedia: Centers for Disease Control and PreventionTags: Drugmaker, Europe, Germany, GlaxoSmithKline, North America, swine flu, Tested, Vaccination, vaccine
Online Health & Fitness News Press Release Distribution - WiredPRNews.com
- Insomniacs Failing Drugs Suffer from Sleep Apnea
- Camfil Air Filter Company Reports - Air Filtration Reduces Risk of Swine Viruses
- Commercial Air Filter Company Camfil.us Demonstrates How Air Filters Stack Up
- Indoor Air Quality: A Growing Risk for School — But One That Can be Tackled
- Viva Healthy Life – The Center for Holistic Medicine in Northeast Philadelphia
- MSrelief.com Announces Special Needs Travel Advocate as Associate Partner
- Hospitals Risk Losing Medicare Payments if Infections Aren’t Reduced
- Alexander R. Vaccaro, M.D., Ph.D., Elected President of Rothman Institute
- Managing Pain Can Help Patients Regain their Lives at Colorado Pain
- Losing Weight Starts With Knowing the Glycemic Index & Glycemic Load Of Foods